Xiong Zhang
Xiong Zhang has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Renshi Xu
Department of Neurology , Jiangxi Provincial People’s Hospital , Nanchang 330006 , Jiangxi , China
11 shared publications Dongcheng Li
Southern Medical University
4 shared publicationsHao Li
Maoming people's hospital
4 shared publicationsJiaxin Chen
Dongguan Chang’an Hospital
4 shared publications- Jie Zhang
Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi, China; Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Nanchang University, Nanchang 330006, Jiangxi, China
4 shared publications Qishan He
Leliu Hospital Affiliated with Shunde Hospital of Guangzhou University of Chinese Medicine
4 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1854469
Deep medullary veins score is associated with idiopathic normal pressure hydrocephalus in patients with arteriolosclerotic cerebral small vessel disease
Objective: This study aimed to investigate the association between deep medullary veins (DMVs) score and comorbid idiopathic normal pressure hydrocephalus (iNPH) in patients with arteriolosclerotic cerebral small vessel disease (aCSVD), and to analyze its role as an independent associated factor. Methods: A total of 80 patients with aCSVD, 40 patients with arteriolosclerotic cerebral small vessel disease comorbid with idiopathic normal pressure hydrocephalus (aCSVD-iNPH), and 30 healthy controls were enrolled. All participants underwent 3.0-T brain MRI to assess DMVs score, periventricular white matter hyperintensity (PVWMH) volume, deep white matter hyperintensity (DWMH) volume, lacunes, cerebral microbleeds, and total CSVD burden score. Clinical and laboratory data were also collected. Multivariate logistic regression was used to identify independent associated factors, and receiver operating characteristic (ROC) curves were employed to evaluate the discriminative ability of the identified factors for group allocation. Results: The DMVs score in the aCSVD-iNPH group (15.29 ± 3.67) was significantly higher than that in the aCSVD group (11.73 ± 2.83) and the healthy control group (11.57 ± 1.79) ( P < 0.001). Multivariate logistic regression showed that DMVs score (OR = 1.499, 95%CI: 1.212–1.855, P < 0.001) and PVWMH volume (OR = 1.070, 95%CI: 1.018–1.124, P = 0.007) were independent associated factors for aCSVD-iNPH. The combined model incorporating both DMVs score and PVWMH volume achieved a higher area under the ROC curve (0.863) than either indicator alone, with a sensitivity of 72.5% and a specificity of 90.0%. Conclusion: Elevated DMVs score is associated with comorbid iNPH in aCSVD patients and serves as an independent associated factor. The combination of DMVs score and PVWMH volume may represent a promising imaging biomarker for identifying individuals with aCSVD-iNPH, pending prospective validation.
- 25 August 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1854469
Open AccessDeep medullary veins score is associated with idiopathic normal pressure hydrocephalus in patients with arteriolosclerotic cerebral small vessel disease
Objective: This study aimed to investigate the association between deep medullary veins (DMVs) score and comorbid idiopathic normal pressure hydrocephalus (iNPH) in patients with arteriolosclerotic cerebral small vessel disease (aCSVD), and to analyze its role as an independent associated factor. Methods: A total of 80 patients with aCSVD, 40 patients with arteriolosclerotic cerebral small vessel disease comorbid with idiopathic normal pressure hydrocephalus (aCSVD-iNPH), and 30 healthy controls were enrolled. All participants underwent 3.0-T brain MRI to assess DMVs score, periventricular white matter hyperintensity (PVWMH) volume, deep white matter hyperintensity (DWMH) volume, lacunes, cerebral microbleeds, and total CSVD burden score. Clinical and laboratory data were also collected. Multivariate logistic regression was used to identify independent associated factors, and receiver operating characteristic (ROC) curves were employed to evaluate the discriminative ability of the identified factors for group allocation. Results: The DMVs score in the aCSVD-iNPH group (15.29 ± 3.67) was significantly higher than that in the aCSVD group (11.73 ± 2.83) and the healthy control group (11.57 ± 1.79) ( P < 0.001). Multivariate logistic regression showed that DMVs score (OR = 1.499, 95%CI: 1.212–1.855, P < 0.001) and PVWMH volume (OR = 1.070, 95%CI: 1.018–1.124, P = 0.007) were independent associated factors for aCSVD-iNPH. The combined model incorporating both DMVs score and PVWMH volume achieved a higher area under the ROC curve (0.863) than either indicator alone, with a sensitivity of 72.5% and a specificity of 90.0%. Conclusion: Elevated DMVs score is associated with comorbid iNPH in aCSVD patients and serves as an independent associated factor. The combination of DMVs score and PVWMH volume may represent a promising imaging biomarker for identifying individuals with aCSVD-iNPH, pending prospective validation.
- Open Access
- 31 July 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1865573
White matter hyperintensity drives EEG microstate abnormalities in arteriosclerotic cerebral small vessel disease
Objectives: Although MRI is the optimal imaging method for assessing white matter hyperintensity (WMH), it lacks sensitivity to the underlying pathophysiological changes of WMH. This study aims to investigate EEG changes associated with WMH and identify potential EEG biomarkers for WMH-related dementia. Methods: This cross-sectional study enrolled 90 subjects: 30 patients with WMH with dementia (WMHD), 30 patients with WMH without dementia (WMH-ND), and 30 age-and sex-matched healthy controls. Brain MRI was used to segment and quantify deep, periventricular, and total WMH volumes (DWMH, PVWMH, TWMH). Resting-state EEG data were recorded for microstate analysis. Four microstate classes (A, B, C, D) were extracted, and their occurrence, mean duration, time coverage, and transition probabilities were calculated. Partial correlation analysis was used to evaluate the associations between microstate features and WMH volume as well as MMSE scores. Based on microstate features, classification prediction models were constructed using machine learning algorithm. Results: In the WMHD group, the temporal parameters (occurrence, mean duration, time coverage) of microstate C were decreased ( P < 0.05–0.001), while the mean duration of microstates A and B was prolonged ( P < 0.05–0.001). The WMH-ND group also showed reduced microstate C temporal parameters ( P < 0.001), but exhibited compensatory increases in mean duration and time coverage of microstate D ( P < 0.001). Transition probabilities toward microstate C were reduced in both patient groups ( P < 0.001), and all transition probabilities toward microstate D were lower in WMHD than in WMH-ND ( P < 0.05–0.001). Temporal parameters of microstates A and B and transition probabilities toward them were positively correlated with WMH volume and negatively correlated with MMSE score. Conversely, those of microstate D showed the opposite correlations. For distinguishing WMHD from WMH-ND, support vector machine (SVM) and logistic regression (LR) performed best (accuracy: 76.67%, AUC: 0.84). Classification performance was highest for WMH-ND vs. HC (LR: 79.17%, AUC 0.86), and lowest for WMHD vs. HC (SVM: 68.33%, AUC 0.77). Conclusion: Patients with WMH exhibit alterations in EEG microstate features that are significantly correlated with WMH burden and cognitive function. Classification models based on these microstate features show promise for practical application in WMH-related dementia.
- 31 July 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1865573
Open AccessWhite matter hyperintensity drives EEG microstate abnormalities in arteriosclerotic cerebral small vessel disease
Objectives: Although MRI is the optimal imaging method for assessing white matter hyperintensity (WMH), it lacks sensitivity to the underlying pathophysiological changes of WMH. This study aims to investigate EEG changes associated with WMH and identify potential EEG biomarkers for WMH-related dementia. Methods: This cross-sectional study enrolled 90 subjects: 30 patients with WMH with dementia (WMHD), 30 patients with WMH without dementia (WMH-ND), and 30 age-and sex-matched healthy controls. Brain MRI was used to segment and quantify deep, periventricular, and total WMH volumes (DWMH, PVWMH, TWMH). Resting-state EEG data were recorded for microstate analysis. Four microstate classes (A, B, C, D) were extracted, and their occurrence, mean duration, time coverage, and transition probabilities were calculated. Partial correlation analysis was used to evaluate the associations between microstate features and WMH volume as well as MMSE scores. Based on microstate features, classification prediction models were constructed using machine learning algorithm. Results: In the WMHD group, the temporal parameters (occurrence, mean duration, time coverage) of microstate C were decreased ( P < 0.05–0.001), while the mean duration of microstates A and B was prolonged ( P < 0.05–0.001). The WMH-ND group also showed reduced microstate C temporal parameters ( P < 0.001), but exhibited compensatory increases in mean duration and time coverage of microstate D ( P < 0.001). Transition probabilities toward microstate C were reduced in both patient groups ( P < 0.001), and all transition probabilities toward microstate D were lower in WMHD than in WMH-ND ( P < 0.05–0.001). Temporal parameters of microstates A and B and transition probabilities toward them were positively correlated with WMH volume and negatively correlated with MMSE score. Conversely, those of microstate D showed the opposite correlations. For distinguishing WMHD from WMH-ND, support vector machine (SVM) and logistic regression (LR) performed best (accuracy: 76.67%, AUC: 0.84). Classification performance was highest for WMH-ND vs. HC (LR: 79.17%, AUC 0.86), and lowest for WMHD vs. HC (SVM: 68.33%, AUC 0.77). Conclusion: Patients with WMH exhibit alterations in EEG microstate features that are significantly correlated with WMH burden and cognitive function. Classification models based on these microstate features show promise for practical application in WMH-related dementia.
- Open Access
- 30 July 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1862595
Clinical analysis of 48 patients with carotid web diagnosed by digital subtraction angiography
Objective: To investigate the clinical characteristics, imaging features, relationship with ischemic stroke, treatment strategies, and follow-up outcomes of patients with carotid web (CaW) diagnosed by digital subtraction angiography (DSA), in order to improve the understanding and clinical management of CaW. Methods: A retrospective analysis was conducted on the clinical data of 48 patients diagnosed with CaW by DSA in the Department of Cerebrovascular Diseases, Zhuhai People’s Hospital from December 2021 to June 2025. Data included baseline characteristics, imaging findings, treatment methods, and follow-up results. All clinical outcomes (ischemic stroke, transient ischemic attack, recurrent ipsilateral ischemic event) were defined a priori according to the American Heart Association/American Stroke Association 2013 (stroke) and 2009 (tissue-based TIA) criteria, and follow-up imaging (carotid Doppler at 6 and 12 months, with brain MRI ± MRA/CTA when clinically indicated) was standardized across all patients. Results: The 48 patients aged from 28 to 83 years, with a mean age of (60.81 ± 11.58). There were 26 males (54.17%) and 22 females (45.83%). All lesions were located at the carotid bifurcation or the origin of the internal carotid artery. The typical DSA manifestation was a thin, linear or membranous filling defect originating from the vessel wall. Among the 48 patients, 13 had a history of smoking, 12 of alcohol consumption, 17 had hypertension, 18 had hyperlipidemia, 7 had diabetes mellitus, 2 had hyperhomocysteinemia, and 4 had hyperuricemia. There were 24 cases of left-sided CaW, 21 cases of right-sided CaW, and 3 cases of bilateral CaW. Subweb thrombus was present in 22 cases (45.83%). Acute ischemic stroke events occurred in 9 cases (18.75%). Treatment modalities included antiplatelet or anticoagulant therapy alone, endovascular interventional therapy, and surgical resection. Specifically, 34 patients received medication alone, 1 underwent emergency endovascular thrombectomy, 1 underwent carotid endarterectomy, 4 underwent carotid artery stenting, and 8 received no treatment. Patients were followed up for 3 to 12 months. One patient in the medication group experienced recurrence of ipsilateral cerebral infarction, while no ischemic events occurred in the remaining patients. “Recurrence” was defined as a new ipsilateral ischemic event occurring ≥24 h after the index event and meeting the AHA/ASA 2013 criteria. All patients completed the 12 month clinical follow-up; loss-to-follow-up was 0%. Conclusion: In this retrospective, non-randomized cohort, the observed rate of recurrent ipsilateral ischemic events was numerically lower among patients who received active endovascular treatment (0/6) than among those who received medical therapy alone (1/34). However, given the very small number of patients who received active intervention, the short follow-up (3–12 months), and the non-randomized, indication-based treatment allocation, no causal inference can be drawn from these data regarding the efficacy of endovascular treatment in preventing stroke recurrence. The observed difference should be interpreted as hypothesis-generating only and requires confirmation in adequately powered prospective randomized controlled trials. Carotid web is an important risk factor for cryptogenic stroke across all age groups. DSA remains the diagnostic gold standard. For patients who have already experienced ischemic events or who have subweb thrombus, active endovascular treatment represents a potentially useful therapeutic option that warrants further evaluation.
- 30 July 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1862595
Open AccessClinical analysis of 48 patients with carotid web diagnosed by digital subtraction angiography
Objective: To investigate the clinical characteristics, imaging features, relationship with ischemic stroke, treatment strategies, and follow-up outcomes of patients with carotid web (CaW) diagnosed by digital subtraction angiography (DSA), in order to improve the understanding and clinical management of CaW. Methods: A retrospective analysis was conducted on the clinical data of 48 patients diagnosed with CaW by DSA in the Department of Cerebrovascular Diseases, Zhuhai People’s Hospital from December 2021 to June 2025. Data included baseline characteristics, imaging findings, treatment methods, and follow-up results. All clinical outcomes (ischemic stroke, transient ischemic attack, recurrent ipsilateral ischemic event) were defined a priori according to the American Heart Association/American Stroke Association 2013 (stroke) and 2009 (tissue-based TIA) criteria, and follow-up imaging (carotid Doppler at 6 and 12 months, with brain MRI ± MRA/CTA when clinically indicated) was standardized across all patients. Results: The 48 patients aged from 28 to 83 years, with a mean age of (60.81 ± 11.58). There were 26 males (54.17%) and 22 females (45.83%). All lesions were located at the carotid bifurcation or the origin of the internal carotid artery. The typical DSA manifestation was a thin, linear or membranous filling defect originating from the vessel wall. Among the 48 patients, 13 had a history of smoking, 12 of alcohol consumption, 17 had hypertension, 18 had hyperlipidemia, 7 had diabetes mellitus, 2 had hyperhomocysteinemia, and 4 had hyperuricemia. There were 24 cases of left-sided CaW, 21 cases of right-sided CaW, and 3 cases of bilateral CaW. Subweb thrombus was present in 22 cases (45.83%). Acute ischemic stroke events occurred in 9 cases (18.75%). Treatment modalities included antiplatelet or anticoagulant therapy alone, endovascular interventional therapy, and surgical resection. Specifically, 34 patients received medication alone, 1 underwent emergency endovascular thrombectomy, 1 underwent carotid endarterectomy, 4 underwent carotid artery stenting, and 8 received no treatment. Patients were followed up for 3 to 12 months. One patient in the medication group experienced recurrence of ipsilateral cerebral infarction, while no ischemic events occurred in the remaining patients. “Recurrence” was defined as a new ipsilateral ischemic event occurring ≥24 h after the index event and meeting the AHA/ASA 2013 criteria. All patients completed the 12 month clinical follow-up; loss-to-follow-up was 0%. Conclusion: In this retrospective, non-randomized cohort, the observed rate of recurrent ipsilateral ischemic events was numerically lower among patients who received active endovascular treatment (0/6) than among those who received medical therapy alone (1/34). However, given the very small number of patients who received active intervention, the short follow-up (3–12 months), and the non-randomized, indication-based treatment allocation, no causal inference can be drawn from these data regarding the efficacy of endovascular treatment in preventing stroke recurrence. The observed difference should be interpreted as hypothesis-generating only and requires confirmation in adequately powered prospective randomized controlled trials. Carotid web is an important risk factor for cryptogenic stroke across all age groups. DSA remains the diagnostic gold standard. For patients who have already experienced ischemic events or who have subweb thrombus, active endovascular treatment represents a potentially useful therapeutic option that warrants further evaluation.
- Open Access
- 21 May 2025
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19, 1607242
Deep and periventricular white matter hyperintensities exhibit differential metabolic profiles in arteriosclerotic cerebral small vessel disease: an untargeted metabolomics study
Introduction: Although white matter hyperintensities (WMH) are radiologically classified as deep WMH (DWMH) and periventricular WMH (PVWMH) based on spatial distribution, the distinct metabolic perturbations driving their pathogenesis remain incompletely characterized.Methods: This study integrated untargeted metabolomics with MRI phenotyping to delineate metabolic perturbations of WMH in arteriosclerotic cerebral small vessel disease (aCSVD) patients (n = 30) versus controls (n = 29). Plasma metabolic profiles were analyzed using UPLC-MS. Weighted gene correlation network analysis (WGCNA) evaluated associations between metabolite clusters and clinical traits, including DWMH volume, PVWMH volume and total WMH (TWMH) volume.Results: We identified 15, 16, and 16 key metabolites meeting both differential expression and WGCNA hub criteria for DWMH, PVWMH, and TWMH, respectively. Pathway Enrichment identified α-linolenic acid and linoleic acid metabolism as common pathway perturbed across both WMH categories. Key metabolites of the pathway, including docosahexaenoic acid (DHA) and stearidonic acid (SDA), demonstrated robust inverse associations with WMH volumes in confounder-adjusted linear regression models. Notably, both WMH categories share common metabolites, particularly polyunsaturated fatty acids (PUFA), while PVWMH-specific metabolites were primarily carnitine derivatives, and DWMH-specific metabolites were prostaglandin E2 and etodolac.Conclusion: These findings offer new insights into the metabolic mechanisms underlying DWMH and PVWMH in aCSVD. However, the cross-sectional nature of the study does not allow for causal conclusions. Future longitudinal studies are needed to validate the temporal relationships between metabolic perturbations and WMH progression.
- 21 May 2025
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19, 1607242
Open AccessDeep and periventricular white matter hyperintensities exhibit differential metabolic profiles in arteriosclerotic cerebral small vessel disease: an untargeted metabolomics study
Introduction: Although white matter hyperintensities (WMH) are radiologically classified as deep WMH (DWMH) and periventricular WMH (PVWMH) based on spatial distribution, the distinct metabolic perturbations driving their pathogenesis remain incompletely characterized.Methods: This study integrated untargeted metabolomics with MRI phenotyping to delineate metabolic perturbations of WMH in arteriosclerotic cerebral small vessel disease (aCSVD) patients (n = 30) versus controls (n = 29). Plasma metabolic profiles were analyzed using UPLC-MS. Weighted gene correlation network analysis (WGCNA) evaluated associations between metabolite clusters and clinical traits, including DWMH volume, PVWMH volume and total WMH (TWMH) volume.Results: We identified 15, 16, and 16 key metabolites meeting both differential expression and WGCNA hub criteria for DWMH, PVWMH, and TWMH, respectively. Pathway Enrichment identified α-linolenic acid and linoleic acid metabolism as common pathway perturbed across both WMH categories. Key metabolites of the pathway, including docosahexaenoic acid (DHA) and stearidonic acid (SDA), demonstrated robust inverse associations with WMH volumes in confounder-adjusted linear regression models. Notably, both WMH categories share common metabolites, particularly polyunsaturated fatty acids (PUFA), while PVWMH-specific metabolites were primarily carnitine derivatives, and DWMH-specific metabolites were prostaglandin E2 and etodolac.Conclusion: These findings offer new insights into the metabolic mechanisms underlying DWMH and PVWMH in aCSVD. However, the cross-sectional nature of the study does not allow for causal conclusions. Future longitudinal studies are needed to validate the temporal relationships between metabolic perturbations and WMH progression.
- 27 March 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (11) , 8631-8639
Oral Microbiota and Porphyromonas gingivalis Kgp Genotypes Altered in Parkinson’s Disease with Mild Cognitive Impairment
Cognitive impairment (CI) is a common complication of the non-motor symptoms in Parkinson’s disease (PD), including PD with mild cognitive impairment (PD-MCI) and PD dementia. Recent studies reported the oral dysbiosis in PD and CI, respectively. Porphyromonas gingivalis (P. gingivalis), a pathogen of oral dysbiosis, plays an important role in PD, whose lysine-gingipain (Kgp) could lead to AD-type pathologies. No previous study investigated the composition of oral microbiota and role of P. gingivalis in PD-MCI. This study aimed to investigate the differences of oral microbiota composition, P. gingivalis copy number, and Kgp genotypes among PD-MCI, PD with normal cognition (PD-NC) and periodontal status-matched control (PC) groups. The oral bacteria composition, the copy number of P. gingivalis, and the Kgp genotypes in gingival crevicular fluid from PD-MCI, PD-NC, and PC were analyzed using 16S ribosomal RNA sequencing, quantitative real-time PCR, and MseI restriction. We found that the structures of oral microbiota in PD-MCI group were significantly different compared to that in PD-NC and PC group. The relative abundances of Prevotella, Lactobacillus, Megasphaera, Atopobium, and Howardella were negatively correlated with cognitive score. Moreover, there was a significant difference of Kgp genotypes among the three groups. The predominant Kgp genotypes of P. gingivalis in the PD-MCI group were primarily Kgp II, whereas in the PD-NC group, it was mainly Kgp I. The Kgp II correlated with lower MMSE and MoCA scores, which suggested that Kgp genotypes II is related to cognitive impairment in PD.
- 27 March 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (11) , 8631-8639
Oral Microbiota and Porphyromonas gingivalis Kgp Genotypes Altered in Parkinson’s Disease with Mild Cognitive Impairment
Cognitive impairment (CI) is a common complication of the non-motor symptoms in Parkinson’s disease (PD), including PD with mild cognitive impairment (PD-MCI) and PD dementia. Recent studies reported the oral dysbiosis in PD and CI, respectively. Porphyromonas gingivalis (P. gingivalis), a pathogen of oral dysbiosis, plays an important role in PD, whose lysine-gingipain (Kgp) could lead to AD-type pathologies. No previous study investigated the composition of oral microbiota and role of P. gingivalis in PD-MCI. This study aimed to investigate the differences of oral microbiota composition, P. gingivalis copy number, and Kgp genotypes among PD-MCI, PD with normal cognition (PD-NC) and periodontal status-matched control (PC) groups. The oral bacteria composition, the copy number of P. gingivalis, and the Kgp genotypes in gingival crevicular fluid from PD-MCI, PD-NC, and PC were analyzed using 16S ribosomal RNA sequencing, quantitative real-time PCR, and MseI restriction. We found that the structures of oral microbiota in PD-MCI group were significantly different compared to that in PD-NC and PC group. The relative abundances of Prevotella, Lactobacillus, Megasphaera, Atopobium, and Howardella were negatively correlated with cognitive score. Moreover, there was a significant difference of Kgp genotypes among the three groups. The predominant Kgp genotypes of P. gingivalis in the PD-MCI group were primarily Kgp II, whereas in the PD-NC group, it was mainly Kgp I. The Kgp II correlated with lower MMSE and MoCA scores, which suggested that Kgp genotypes II is related to cognitive impairment in PD.
- Open Access
- 16 November 2023
- Published by Springer Nature in Research Square
Oral Microbiota and Porphyromonas Gingivalis Kgp Genotypes Altered in Parkinson’s Disease with Mild Cognitive Impairment
Cognitive impairment (CI) is a common complication of the non-motor symptoms in Parkinson’s disease (PD), including PD with mild cognitive impairment (PD-MCI) and PD dementia. Recent studies reported the oral dysbiosis in PD and CI, respectively. Porphyromonas gingivalis (P. gingivalis), a pathogen of oral dysbiosis, play an important role in PD, whose lysine-gingipain (Kgp) could lead to AD-type pathologies. No previous study investigated the composition of oral microbiota and role of P. gingivalisin PD-MCI. This study aimed to investigates the differences of oral microbiota composition, P. gingivalis copy number, and Kgp genotypes among PD-MCI, PD with normal cognition(PD-NC) and periodontal status-matched control (PC) groups. The oral bacteria composition, the copy number of P. gingivalisand the Kgp genotypes in gingival crevicular fluid from PD-MCI, PD-NC, and PC were analyzed using 16S ribosomal RNA sequencing, quantitative real-time PCR, and MseⅠ restriction. We found that the structures of oral microbiota in PD-MCI group were significantly different compared to that in PD-NC and PC group. The relative abundances of Prevotella, Lactobacillus, Megasphaera, Atopobium and Howardella were negatively correlated with cognitive score. Moreover, there was a significant difference of Kgp genotypes among the three groups. The predominant Kgp genotypes of P. gingivalis in the PD-MCI group was primarily Kgp Ⅱ, whereas in the PD-NC group was mainly Kgp Ⅰ. The Kgp Ⅱ correlated with lower MMSE and MoCA scores, suggested that PD-CI may be related to Kgp genotypes Ⅱ.
- 16 November 2023
- Published by Springer Nature in Research Square
Open AccessOral Microbiota and Porphyromonas Gingivalis Kgp Genotypes Altered in Parkinson’s Disease with Mild Cognitive Impairment
Cognitive impairment (CI) is a common complication of the non-motor symptoms in Parkinson’s disease (PD), including PD with mild cognitive impairment (PD-MCI) and PD dementia. Recent studies reported the oral dysbiosis in PD and CI, respectively. Porphyromonas gingivalis (P. gingivalis), a pathogen of oral dysbiosis, play an important role in PD, whose lysine-gingipain (Kgp) could lead to AD-type pathologies. No previous study investigated the composition of oral microbiota and role of P. gingivalisin PD-MCI. This study aimed to investigates the differences of oral microbiota composition, P. gingivalis copy number, and Kgp genotypes among PD-MCI, PD with normal cognition(PD-NC) and periodontal status-matched control (PC) groups. The oral bacteria composition, the copy number of P. gingivalisand the Kgp genotypes in gingival crevicular fluid from PD-MCI, PD-NC, and PC were analyzed using 16S ribosomal RNA sequencing, quantitative real-time PCR, and MseⅠ restriction. We found that the structures of oral microbiota in PD-MCI group were significantly different compared to that in PD-NC and PC group. The relative abundances of Prevotella, Lactobacillus, Megasphaera, Atopobium and Howardella were negatively correlated with cognitive score. Moreover, there was a significant difference of Kgp genotypes among the three groups. The predominant Kgp genotypes of P. gingivalis in the PD-MCI group was primarily Kgp Ⅱ, whereas in the PD-NC group was mainly Kgp Ⅰ. The Kgp Ⅱ correlated with lower MMSE and MoCA scores, suggested that PD-CI may be related to Kgp genotypes Ⅱ.
- Open Access
- 27 January 2023
- Published by Springer Nature in BMC Medical Genomics
- Vol. 16 (1) , 1-17
Three nervous system-specific expressed genes are potential biomarkers for the diagnosis of sporadic amyotrophic lateral sclerosis through a bioinformatic analysis
Background: Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disease in adults. However, ALS, especially sporadic ALS (sALS), is difficult to diagnose due to the lack of biomarkers. Results: We used the bioinformatics technology to find the potential biomarker and we found that two hundred seventy-four DEGs were identified and enrichment analysis showed DEGs were involved in nervous system activity, like axon_guidance and the neurotrophin_signaling_pathway. Five nervous system-specific expressed hub genes were further validated by three GEO datasets. APP, LRRK2, and PSEN1 might be potential diagnostic and prognostic biomarkers of sALS, and NEAT1-miR-373-3p/miR-302c-3p/miR-372-3p-APP, circ_0000002-miR-302d-3p/miR-373-3p-APP and XIST-miR-9-5p/miR-30e-5p/miR-671-5p might be potential ceRNA regulatory pathways. APP SNP analysis showed subjects harboring the minor G allele of rs463946, minor G allele of rs466433 and minor C allele of rs364048 had an increased risk of sALS development. Conclusions: Our results identified three nervous system-specific expressed hub genes that might be diagnostic and prognostic markers of sALS and APP might be a genetic susceptibility factor contributing to sALS development.
- 27 January 2023
- Published by Springer Nature in BMC Medical Genomics
- Vol. 16 (1) , 1-17
Open AccessThree nervous system-specific expressed genes are potential biomarkers for the diagnosis of sporadic amyotrophic lateral sclerosis through a bioinformatic analysis
Background: Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disease in adults. However, ALS, especially sporadic ALS (sALS), is difficult to diagnose due to the lack of biomarkers. Results: We used the bioinformatics technology to find the potential biomarker and we found that two hundred seventy-four DEGs were identified and enrichment analysis showed DEGs were involved in nervous system activity, like axon_guidance and the neurotrophin_signaling_pathway. Five nervous system-specific expressed hub genes were further validated by three GEO datasets. APP, LRRK2, and PSEN1 might be potential diagnostic and prognostic biomarkers of sALS, and NEAT1-miR-373-3p/miR-302c-3p/miR-372-3p-APP, circ_0000002-miR-302d-3p/miR-373-3p-APP and XIST-miR-9-5p/miR-30e-5p/miR-671-5p might be potential ceRNA regulatory pathways. APP SNP analysis showed subjects harboring the minor G allele of rs463946, minor G allele of rs466433 and minor C allele of rs364048 had an increased risk of sALS development. Conclusions: Our results identified three nervous system-specific expressed hub genes that might be diagnostic and prognostic markers of sALS and APP might be a genetic susceptibility factor contributing to sALS development.
- Open Access
- 23 September 2022
- Published by Springer Nature in Research Square
Three nervous system-specific expressed genes are potential biomarkers for the diagnosis of sporadic amyotrophic lateral sclerosis through a bioinformatic analysis
Background Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disease in adults. However, ALS, especially sporadic ALS (sALS), is difficult to diagnose due to the lack of biomarkers. Results We used the Bioinformatics technology to find the potential biomarker and we found that two hundred seventy-four DEGs were identified and enrichment analysis showed DEGs were involved in nervous system activity, like axon_guidance and the neurotrophin_signaling_pathway. Five nervous system-specific expressed hub genes were further validated by three GEO datasets. APP, LRRK2, and PSEN1 might be potential diagnostic and prognostic biomarkers of sALS, and NEAT1-miR-373-3p/miR-302c-3p/miR-372-3p-APP, circ_0000002-miR-302d-3p/miR-373-3p-APP and XIST-miR-9-5p/miR-30e-5p/miR-671-5p might be potential ceRNA regulatory pathways. APP SNP analysis showed subjects harboring the minor G allele of rs463946, minor G allele of rs466433 and minor C allele of rs364048 had an increased risk of sALS development. Conclusions Our results identified three nervous system-specific expressed hub genes that might be diagnostic and prognostic markers of sALS and APP might be a genetic susceptibility factor contributing to sALS development.
- 23 September 2022
- Published by Springer Nature in Research Square
Open AccessThree nervous system-specific expressed genes are potential biomarkers for the diagnosis of sporadic amyotrophic lateral sclerosis through a bioinformatic analysis
Background Amyotrophic lateral sclerosis (ALS) is the most common neurodegenerative disease in adults. However, ALS, especially sporadic ALS (sALS), is difficult to diagnose due to the lack of biomarkers. Results We used the Bioinformatics technology to find the potential biomarker and we found that two hundred seventy-four DEGs were identified and enrichment analysis showed DEGs were involved in nervous system activity, like axon_guidance and the neurotrophin_signaling_pathway. Five nervous system-specific expressed hub genes were further validated by three GEO datasets. APP, LRRK2, and PSEN1 might be potential diagnostic and prognostic biomarkers of sALS, and NEAT1-miR-373-3p/miR-302c-3p/miR-372-3p-APP, circ_0000002-miR-302d-3p/miR-373-3p-APP and XIST-miR-9-5p/miR-30e-5p/miR-671-5p might be potential ceRNA regulatory pathways. APP SNP analysis showed subjects harboring the minor G allele of rs463946, minor G allele of rs466433 and minor C allele of rs364048 had an increased risk of sALS development. Conclusions Our results identified three nervous system-specific expressed hub genes that might be diagnostic and prognostic markers of sALS and APP might be a genetic susceptibility factor contributing to sALS development.
- 23 September 2022
- Published by Wolters Kluwer Health in Cognitive and Behavioral Neurology
- Vol. 35 (4) , 230-246
The Account of the Effect of Switch Probability on Switch and Mixing Costs: An ERP Study in a Cued Task-switching Paradigm
Background: Whether the effect of switch probability on switch and mixing costs is explained by an activation or preparation account is unclear. Objective: To investigate the account of the effect of switch probability on switch and mixing costs. Method: We used a cued task-switching paradigm with three switch probabilities (high, 75%; medium, 50%; and low, 25%) with 19 healthy young adults and recorded the cue- and target-locked event-related potentials (ERPs) and behavioral performance. The task included switch and stay trials under high, medium, and low switch conditions, as well as pure trials. Results: There was no significant difference in reaction time (RT) in switch and mixing costs between the high and medium switch conditions. The RT in switch and mixing costs in the high and medium switch conditions was significantly less and more than in the low switch condition, respectively. The cue-locked ERPs revealed significant effects on mixing costs (stay − pure) that were cue early frontal positivity (260–300 ms) in the high and medium switch conditions, and on switch costs (switch − stay) that were cue early central positivity (240–260 ms) in the low switch condition. Moreover, the target-locked ERPs of the mixing costs revealed significant effects on mixing costs that were target P3b (440–540 ms) in all three switch conditions, and on switch costs that were target P3b in the medium and low switch conditions. Conclusion: The effect of switch probability on switch and mixing costs is explained by the activation account.
- 23 September 2022
- Published by Wolters Kluwer Health in Cognitive and Behavioral Neurology
- Vol. 35 (4) , 230-246
The Account of the Effect of Switch Probability on Switch and Mixing Costs: An ERP Study in a Cued Task-switching Paradigm
Background: Whether the effect of switch probability on switch and mixing costs is explained by an activation or preparation account is unclear. Objective: To investigate the account of the effect of switch probability on switch and mixing costs. Method: We used a cued task-switching paradigm with three switch probabilities (high, 75%; medium, 50%; and low, 25%) with 19 healthy young adults and recorded the cue- and target-locked event-related potentials (ERPs) and behavioral performance. The task included switch and stay trials under high, medium, and low switch conditions, as well as pure trials. Results: There was no significant difference in reaction time (RT) in switch and mixing costs between the high and medium switch conditions. The RT in switch and mixing costs in the high and medium switch conditions was significantly less and more than in the low switch condition, respectively. The cue-locked ERPs revealed significant effects on mixing costs (stay − pure) that were cue early frontal positivity (260–300 ms) in the high and medium switch conditions, and on switch costs (switch − stay) that were cue early central positivity (240–260 ms) in the low switch condition. Moreover, the target-locked ERPs of the mixing costs revealed significant effects on mixing costs that were target P3b (440–540 ms) in all three switch conditions, and on switch costs that were target P3b in the medium and low switch conditions. Conclusion: The effect of switch probability on switch and mixing costs is explained by the activation account.
- Open Access
- 26 July 2022
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13, 945523
Porphyromonas gingivalis: A key role in Parkinson's disease with cognitive impairment?
Cognitive impairment (CI) is a common complication of Parkinson's disease (PD). The major features of Parkinson's disease with cognitive impairment (PD-CI) include convergence of α-Synuclein (α-Syn) and Alzheimer's disease (AD)-like pathologies, neuroinflammation, and dysbiosis of gut microbiota. Porphyromonas gingivalis (P. gingivalis) is an important pathogen in periodontitis. Recent research has suggested a role of P. gingivalis and its virulence factor in the pathogenesis of PD and AD, in particular concerning neuroinflammation and deposition of α-Synuclein (α-Syn) and amyloid-β (Aβ). Furthermore, in animal models, oral P. gingivalis could cause neurodegeneration through regulating the gut-brain axis, suggesting an oral-gut-brain axis might exist. In this article, we discussed the pathological characteristics of PD-CI and the role of P. gingivalis in them.
- 26 July 2022
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13, 945523
Open AccessPorphyromonas gingivalis: A key role in Parkinson's disease with cognitive impairment?
Cognitive impairment (CI) is a common complication of Parkinson's disease (PD). The major features of Parkinson's disease with cognitive impairment (PD-CI) include convergence of α-Synuclein (α-Syn) and Alzheimer's disease (AD)-like pathologies, neuroinflammation, and dysbiosis of gut microbiota. Porphyromonas gingivalis (P. gingivalis) is an important pathogen in periodontitis. Recent research has suggested a role of P. gingivalis and its virulence factor in the pathogenesis of PD and AD, in particular concerning neuroinflammation and deposition of α-Synuclein (α-Syn) and amyloid-β (Aβ). Furthermore, in animal models, oral P. gingivalis could cause neurodegeneration through regulating the gut-brain axis, suggesting an oral-gut-brain axis might exist. In this article, we discussed the pathological characteristics of PD-CI and the role of P. gingivalis in them.